Nicotine and the hallucinating brain: Effects on mismatch negativity (MMN) in schizophrenia

Psychiatry Research

Volumn 196, Issue 2-3, 2012, Pages 181-187

  Fisher, Derek J ^a,b,c,d   Grant, Bryan ^c   Smith, Dylan M ^c   Borracci, Giuseppe ^d   Labelle, Alain ^c,d   Knott, Verner J ^b,c,d  

^a MOUNT SAINT VINCENT UNIVERSITY   (Canada)

^b CARLETON UNIVERSITY   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d ROYAL OTTAWA HOSPITAL   (Canada)

Author keywords

Auditory event related potentials; Auditory hallucinations; Mismatch negativity; MMN; Nicotine; Schizophrenia; Tobacco

Indexed keywords

NICOTINE; PLACEBO;

ADULT; ARTICLE; AUDITORY HALLUCINATION; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELECTROPHYSIOLOGY; HUMAN; LATENT PERIOD; MISMATCH NEGATIVITY; OUTPATIENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PULSE RATE; SCHIZOPHRENIA; SYSTOLIC BLOOD PRESSURE;

ACOUSTIC STIMULATION; ADULT; BLOOD PRESSURE; BRAIN; CONTINGENT NEGATIVE VARIATION; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; FEMALE; HALLUCINATIONS; HEART RATE; HUMANS; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA;

EID: 84862790566     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2012.01.026     Document Type: Article

References (75)

1. Adler L.E., Hoffer D.L., Wiser A., Freedom R. Normalization of auditory physiology by cigarette smoking in schizophrenia patients. The American Journal of Psychiatry 1993, 150:1856-1861.
2. Anfang M.K., Pope H.G. Treatment of neuroleptic-induced akathisia with nicotine patches. Psychopharmacology 1997, 134:153-156.
3. Baldeweg T., Wong D., Stephan K.E. Nicotinic modulation of human auditory sensory memory: evidence from mismatch negativity potentials. International Journal of Psychophysiology 2006, 59:49-58.
4. Cadenhead K.S., Braff D.L. Schizophrenia spectrum disorders. Startle Modification: Implications for Neuroscience, Cognitive Science, and Clinical Science 1999, 231-244. Cambridge University Press, Cambridge. M.E. Dawson, A.M. Schell, A.H. Bohmelt (Eds.).
5. Catts S.V., Shelley A.M., Ward P.B., Liebert B., McConaghy N., Andrews S., Michie P.T. Brain potential evidence for an auditory sensory memory deficit in schizophrenia. The American Journal of Psychiatry 1995, 152:213-219.
6. de Leon J., Diaz F.J., Rogers T., Browne D., Dinsmore L. Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders. Schizophrenia Research 2002, 56:47-54.
7. Dulude L., Labelle A., Knott V.J. Acute nicotine alteration of sensory memory impairment in smokers with schizophrenia. Journal of Clinical Psychopharmacology 2010, 30:541-548.
8. Dunbar G., Boeijinga P.H., Demazières A., Cisterni C., Kuchibhatla R., Wesnes K., Luthringer R. Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers. Psychopharmacology 2007, 191:919-929.
9. Evans D.E., Drobes D.J. Nicotine self-mediation of cognitive-attentional processing. Addiction Biology 2008, 14:32-42.
10. Fisher D.J., Labelle A., Knott V.J. The right profile: mismatch negativity in schizophrenia with and without auditory hallucinations as measured by a multi-feature paradigm. Clinical Neurophysiology 2008, 119:919-921.
11. Fisher D.J., Labelle A., Knott V.J. Auditory hallucinations and the mismatch negativity: processing speech and non-speech sounds in schizophrenia. International Journal of Psychophysiology 2008, 70:3-15.
12. Fisher D.J., Grant B., Smith D.M., Knott V.J. Effects of deviant probability on the 'optimal' multi-feature mismatch negativity (MMN) paradigm. International Journal of Psychophysiology 2011, 79:311-315.
13. Fisher D.J., Grant B., Smith D.M., Borracci G., Labelle A., Knott V.J. Effects of auditory hallucinations on the mismatch negativity (MMN) in schizophrenia as measured by a modified 'optimal' multi-feature paradigm. International Journal of Psychophysiology 2011, 81:245-251.
14. Ford J.M., Roach B.J., Jorgensen K.W., Turner J.A., Brown G.G., Notestine R., Bischoff-Grethe A., Greve D., Wible C., Lauriello J., Belger A., Mueller B.A., Calhoun V., Preda A., Keator D., O'Leary D.S., Lim K.O., Glover G., Potkin S.G., FBIRN, Mathalon D.H. Tuning in to the voices: a multisite fMRI study of auditory hallucinations. Schizophrenia Bulletin 2009, 35:58-66.
15. Friedman J., Horvath T. Tobacco smoking and a stimulus barrier. Nature 1974, 248:455-456.
16. Giard M., Lavikainen J., Reinikainen K., Perria F., Bertrand O., Pernier J., Näätänen R. Separate representations of stimulus, frequency, intensity and duration in auditory sensory memory: an event-related potential and dipole-model analysis. Journal of Cognitive Neuroscience 1995, 7:133-143.
17. Gratton G., Coles M.G., Donchin E. A new method for off-line removal of ocular artifact. Electroencephalography and Clinical Neurophysiology 1983, 55:468-484.
18. Haddock G., McCarron J., Tarrier N., Faragher E.B. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychological Medicine 1999, 29:879-888.
19. Harkrider A.W., Champlin C.A. Acute effect of nicotine on non-smokers: II. MLRs and 40-Hz responses. Hearing Research 2001, 160:89-98.
20. Harkrider A.W., Hedrick M.S. Acute effect of nicotine on auditory gating in smokers and non-smokers. Hearing Research 2005, 202:114-128.
21. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerström K.O. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction 1991, 86:1119-1127.
22. Hillyard S.A., Kutas M. Electrophysiology of cognitive processing. Annual Review of Psychology 1983, 34:33-61.
23. Hirayasu Y., Potts G.F., O'Donnell B.F., Kwon J.S., Arakaki H., Akdaq S.J., Levitt J.J., Shenton M.E., McCarley R.W. Auditory mismatch negativity in schizophrenia: topographic evaluation with a high-density recording montage. The American Journal of Psychiatry 1998, 155:1281-1283.
24. Hong L.E., Schroeder M., Ross T.J., Buchholz B., Salmeron B.J., Wonodi I., Thaker G.K., Stein E.A. Nicotine enhances but does not normalize visual sustained attention and the associated brain network in schizophrenia. Schizophrenia Bulletin 2011, 37:416-425.
25. Horton J., Millar A., Labelle A., Knott V.J. MMN responsivity to manipulations of frequency and duration deviants in chronic, clozapine-treated schizophrenia patients. Schizophrenia Research 2011, 126:202-211.
26. Hughes J.R., Hatsukami D. Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry 1986, 43:289-294.
27. Hukkanen J., Jacob P., Benowitz N.L. Metabolism and disposition kinetics of nicotine. Pharmacology Review 2005, 57:79-115.
28. Inami R., Kirino E., Inoue R., Arai H. Transdermal nicotine administration enhances automatic auditory processing reflected by mismatch negativity. Pharmacology, Biochemistry and Behaviour 2005, 80:453-461.
29. Inami R., Kirino E., Inoue R., Suzuki T., Arai H. Nicotine effects on mismatch negativity in nonsmoking schizophrenic patients. Neuropsychobiology 2007, 56:64-72.
30. Janhunen S., Ahtee L. Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: implications for drug development. Neuroscience and Biobehavioural Reviews 2007, 31:287-314.
31. Javitt D.C., Doneshka P., Grochowski S., Ritter W. Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia. Archives of General Psychiatry 1995, 52:550-558.
32. Javitt D.C., Grochowski S., Shelley A.M., Ritter W. Impaired mismatch negativity (MMN) generation in schizophrenia as a function of stimulus deviance, probability, and interstimulus/interdeviant interval. Electroencephalography and Clinical Neurophysiology 1998, 108:143-153.
33. Kassel J.D. Smoking and attention: a review and reformulation of the stimulus-filter hypothesis. Clinical Psychology Review 1997, 17:451-478.
34. Kay S.R., Opler L.A., Lindenmeyer J.P. The positive and negative syndrome scale (PANSS): rationale and standardization. The British Journal of Psychiatry 1989, 155(Suppl 7):59-65.
35. Kelly C., McCreadie R.G. Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. The American Journal of Psychiatry 1999, 156:1751-1757.
36. Knapp D.E., Domino E.F. Action of nicotine on the ascending reticular activating system. International Journal of Neuropharmacology 1962, 1:333-351.
37. Knott V.J., Venables P.H. Stimulus control and the cortical evoked response in smokers and non-smokers. Psychophysiology 1978, 15:186-192.
38. Kramer A.F., Trejo L.J., Humphrey D. Assessment of mental workload with task-irrelevant auditory probes. Biological Psychology 1995, 40:83-100.
39. Kumari V., Postma P. Nicotine use in schizophrenia: the self medication hypotheses. Neuroscience and Biobehavioural Reviews 2005, 29:1021-1034.
40. Kumari V., Soni W., Sharma T. Influence of cigarette smoking on prepulse inhibition of the acoustic startle response in schizophrenia. Human Psychopharmacology and Clinical Experience 2001, 16:321-326.
41. Leonard S., Gault J., Hopkins J., Logel J., Vianzon R., Short M., Drebing C., Berger R., Venn D., Sirota P., Zerbe G., Ollincy A., Ross R.G., Adler L.E., Freedman R. Association of promoter variants in the a7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrena. Archives of General Psychiatry 2002, 59:1085-1096.
42. Lerman C., Niaura R. Applying genetic approaches to the treatment of nicotine dependence. Oncogene 2002, 21:7412-7420.
43. Leung S., Croft R.J., Guille V., Nathan P.J. The effects of digital filtering on duration MMN. Presented at the 4th Conference on Mismatch Negativity and Its Clinical and Scientific Applications, Cambridge UK, April 22-26 2006.
44. Margo A., Helmsley D.R., Slade P.D. The effects of varying auditory input on schizophrenia hallucinations. The British Journal of Psychiatry 1981, 139:122-127.
45. Martin L.F., Davalos D.B., Kisley M.A. Nicotine enhances automatic temporal processing as measured by the mismatch negativity waveform. Nicotine & Tobacco Research 2009, 11:698-706.
46. Michie P. What has MMN revealed about the auditory system in schizophrenia?. International Journal of Psychophysiology 2001, 42:177-194.
47. Milailescu S., Drucker-Colin R. Nicotine and brain disorders. Acta Pharmacologica Sinica 2000, 21:97-104.
48. Näätänen R. Attention and Brain Function 1992, Lawrence Earlbaum Associates, Hillsdale, NJ.
49. Näätänen R. Mismatch negativity: clinical research and possible applications. International Journal of Psychophysiology 2003, 48:179-188.
50. Näätänen R., Ahlo K. Mismatch negativity - the measure for central sound represenation accuracy. Audiology & Neuro-Otology 1997, 2:341-353.
51. Näätänen R., Kähkönen S. Central auditory dysfunction in schizophrenia as revealed by the mismatch negativity (MMN) and its magnetic equivalent MMNm: a review. The International Journal of Neuropsychopharmacology 2009, 12:125-135.
52. Näätänen R., Pakarinen S., Rinne T., Takegata R. The mismatch negativity (MMN) - towards the optimal paradigm. Clinical Neurophysiology 2004, 115:140-144.
53. Näätänen R., Paavilainen P., Rinne T., Alho K. The mismatch negativity (MMN) in basic research of central auditory processing: a review. Clinical Neurophysiology 2007, 118:2544-2590.
54. Newhouse P.A., Potter A., Singh A. Effects of nicotine stimulation on cognitive performance. Current Opinion in Pharmacology 2004, 4:36-46.
55. Oades R., Zerbin D., Dittman-Balcar A., Eggers C. Auditory event-related potential (ERP) and difference-wave topography in schizophrenia patients with/without active hallucinations and delusions: a comparison with young obsessive-compulsive disorder (OCD) and healthy subjects. International Journal of Psychophysiology 1996, 22:185-214.
56. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9:97-113.
57. Olincy A., Young D.A., Freedman R. Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biological Psychiatry 1997, 42:1-5.
58. Rasser P., Schall V., Todd J., Michie P.T., Ward P.B., Johnston P., Helmbold K., Case V., Søyland A., Tooney P.A., Thompson P.M. Gray matter deficits, mismatch negativity, and outcomes in schizophrenia. Schizophrenia Bulletin 2011, 37:131-140.
59. Sacco K.A., Termine A., Seval A., Dudas M.M., Vessichio J.C., Krishnan-Sarin S., Jatlow P.I., Wexler B.E., George T.P. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Archives of General Psychiatry 2005, 62:649-659.
60. Schall U., Catts S.V., Karayanidis F., Ward P.B. Auditory event-related potential indices of fronto-temporal information processing in schizophrenia syndromes: valid outcome prediction of clozapine therapy in a three-year follow up. The International Journal of Neuropsychopharmacology 1999, 2:83-93.
61. Shelley A.M., Ward P.B., Catts S.V., Michie P.T., Andrews S., McConaghy N. Mismatch negativity: an index of a preattentive processing deficit in schizophrenia. Biological Psychiatry 1991, 30:1059-1062.
62. Singh A., Potter A., Newhouse P. Nicotinic acetylcholine receptor system and neuropsychiatric disorders. The Investigational Drugs Journal 2004, 7:1096-1103.
63. Sjoberg N., Saint D.A. A single 4mg dose of nicotine decreases heart rate variability in healthy nonsmokers: implications for smoking cessation programs. Nicotine and Tobacco Research 2011, 13:369-372.
64. Strand J.E., Nyback H. Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls. European Psychiatry 2005, 20:50-54.
65. Tanabe J., Tregellas J.R., Martin L.F., Freedman R. Effects of nicotine on hippocampal and cingulate activity during smooth pursuit eye movement in schizophrenia. Biological Psychiatry 2006, 59:754-761.
66. Thönnessen H., Zvyagintsev M., Harke K.C., Boers F., Dammers J., Norra Ch., Mathiak K. Optimized mismatch negativity paradigm reflects deficits in schizophrenia patients: a combined EEG and MEG study. Biological Psychology 2008, 77:205-216.
67. Tiffany S.T., Drobes D.J. The development and initial validation of a questionnaire on smoking urges. British Journal of Addiction 1992, 86:1467-1476.
68. Todd J., Michie P.T., Schall U., Karayanidis F., Yabe H., Näätänen R. Deviant matters: duration, frequency, and intensity deviants reveal different patterns of mismatch negativity reduction in early and late schizophrenia. Biological Psychiatry 2008, 63:58-64.
69. Uck A., Polat A., Bozkurt O., Meteris H. Cigarette smoking among patients with schizophrenia and bipolar disorders. Psychiatry and Clinical Neurosciences 2004, 58:434-437.
70. Umbricht D., Krljes S. Mismatch negativity in schizophrenia: a meta-analysis. Schizophrenia Research 2005, 76:1-23.
71. Umbricht D., Javitt D.C., Bates J., Kane J., Lieberman J.A. How specific are deficits in mismatch negativity generation to schizophrenia?. Biological Psychiatry 2003, 53:1120-1131.
72. Wignall N.D., de Wit H. Effects of nicotine on attention and inhibitory control in healthy nonsmokers. Experimental and Clinical Psychopharmacology 2011, 19:183-191.
73. Woodruff P.W. Auditory hallucinations: insights and questions from neuroimaging. Cognitive Neuropsychiatry 2004, 9:73-91.
74. Wynn S., Sugar C., Horan W., Kern R., Green M. Mismatch negativity, social cognition, and functioning in schizophrenia patients. Biological Psychiatry 2010, 67:940-947.
75. Youn T., Park H.-J., Kim J.-J., Kim M.S., Kwon J.S. Altered hemispheric asymmetry and positive symptoms in schizophrenia: equivalent current dipole of auditory mismatch negativity. Schizophrenia Research 2002, 59:253-260.